RecallDepth
Class II Ongoing

Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd for: Northstar Rx LLC, Memphis, TN, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh India, NDC 16714-555-01.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
November 1, 2024
Posted
December 11, 2024
Recall Number
D-0098-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
7296 bottles
Firm Location
Mahwah, NJ, United States

Reason for Recall

cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls